Hemogenyx Pharmaceuticals Pink Sheet Forecast - Naive Prediction

HOPHF Stock  USD 0  0.00  0.00%   
The Naive Prediction forecasted value of Hemogenyx Pharmaceuticals Plc on the next trading day is expected to be 0 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Hemogenyx Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Hemogenyx Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A naive forecasting model for Hemogenyx Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Hemogenyx Pharmaceuticals Plc value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Hemogenyx Pharmaceuticals Naive Prediction Price Forecast For the 12th of December 2024

Given 90 days horizon, the Naive Prediction forecasted value of Hemogenyx Pharmaceuticals Plc on the next trading day is expected to be 0 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Hemogenyx Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Hemogenyx Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Hemogenyx Pharmaceuticals Pink Sheet Forecast Pattern

Backtest Hemogenyx PharmaceuticalsHemogenyx Pharmaceuticals Price PredictionBuy or Sell Advice 

Hemogenyx Pharmaceuticals Forecasted Value

In the context of forecasting Hemogenyx Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Hemogenyx Pharmaceuticals' downside and upside margins for the forecasting period are 0 and 0, respectively. We have considered Hemogenyx Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0
0
Expected Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Hemogenyx Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Hemogenyx Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria39.1594
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
This model is not at all useful as a medium-long range forecasting tool of Hemogenyx Pharmaceuticals Plc. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Hemogenyx Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Hemogenyx Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hemogenyx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Hemogenyx Pharmaceuticals. Your research has to be compared to or analyzed against Hemogenyx Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Hemogenyx Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Hemogenyx Pharmaceuticals.

Other Forecasting Options for Hemogenyx Pharmaceuticals

For every potential investor in Hemogenyx, whether a beginner or expert, Hemogenyx Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hemogenyx Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hemogenyx. Basic forecasting techniques help filter out the noise by identifying Hemogenyx Pharmaceuticals' price trends.

Hemogenyx Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hemogenyx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Hemogenyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Hemogenyx Pharmaceuticals Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Hemogenyx Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Hemogenyx Pharmaceuticals' current price.

Hemogenyx Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Hemogenyx Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hemogenyx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Hemogenyx Pharmaceuticals pink sheet market strength indicators, traders can identify Hemogenyx Pharmaceuticals Plc entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

Other Information on Investing in Hemogenyx Pink Sheet

Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.